olverembatinib,ponatinib
incyte,otsuka,ascentage pharmaceuticals,innovent biologics,takeda
['olverembatinib', 'cml', 'ponatinib', 'leusm']
olverembatinib elicits efficacy in us patients with ponatinib-resistant, t315i-mutant cml, and ph-positive all #ash22 #leusm 
Healthcare publisher of oncology focused articles, videos, panel discussions, and much more that run the gamut of oncology care and management.